Evidence map›Paper›PMID 35164360›Full record

ArticleMolecules (Basel, Switzerland)2022

Chemical Composition and Synergistic Potential of

Fahima Bekka-Hadji, Isabelle Bombarda, Ferhat Djoudi, Sofiane Bakour, Abdelaziz Touati

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Is Camphor the Future in Supporting Therapy for Skin Infections?Pharmaceuticals (Basel, Switzerland) · 2024
    Review
  11. Life (Basel, Switzerland) · 2024
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Synergistic Interaction betweenEvidence-based complementary and alternative medicine : eCAM · 2023
    Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Fahima Bekka-HadjiDépartement de Microbiologie Appliquée et Sciences Alimentaires, Faculté des Sciences de la Nature et de la Vie, Université de Jijel, Jijel 18000, Algeria.
Isabelle BombardaAix Marseille Univ, Université Avignon, CNRS, IRD, IMBE, 13013 Marseille, France.
Ferhat DjoudiLaboratoire d'Ecologie Microbienne, Faculté des Sciences de la Nature et de la Vie, Université de Bejaia, Bejaia 06000, Algeria.
Sofiane BakourAix Marseille Univ, IRD, APHM, MEPHI, IHU-Méditerranée Infection, 13013 Marseille, France.
Abdelaziz TouatiLaboratoire d'Ecologie Microbienne, Faculté des Sciences de la Nature et de la Vie, Université de Bejaia, Bejaia 06000, Algeria.
University of Béjaïa · DZMéditerranée Infection Foundation · FRUniversité d'Avignon et des Pays de Vaucluse · FRUniversity of Jijel · DZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The essential oils were obtained by hydrodistillation from aerial parts of

Indexed as

Acinetobacter baumanniiAnti-Bacterial AgentsAntioxidantsArtemisiaGas Chromatography-Mass SpectrometryImipenemMentha pulegiumMethicillin-Resistant Staphylococcus aureusMicrobial Sensitivity TestsOils, VolatilePlant OilsAnti-Bacterial AgentsAntioxidantsImipenemOils, VolatilePlant Oilsantibacterial activityantibioticessential oilmulti-drug-resistant bacteriasynergism

Identifiers

PMID35164360
PMCPMC8839733
OpenAlexW4210878336

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.